Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-31 as a Clinical Target for Pruritus Treatment
Kenji Kabashima, Hiroyuki Irie
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Modulation of the Mas-Related G Protein-Coupled Receptor X2 (MRGPRX2) by Xenobiotic Compounds and Its Relevance to Human Diseases
Alicja Dziadowiec, Iwona Popiołek, Mateusz Kwitniewski, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 1, pp. 380-403
Open Access | Times Cited: 2
Current and emerging drugs for the treatment of pruritus: an update of the literature
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
The Future of Atopic Dermatitis Treatment
Katie Lovell, Nupur Patel, Saroja Rao, et al.
Advances in experimental medicine and biology (2024), pp. 227-244
Closed Access | Times Cited: 2
Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 – An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives
Alin Laurențiu Tatu, Thomas Nadasdy, Anca Adriana Arbune, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 5163-5184
Open Access | Times Cited: 11
Mechanistic and Therapeutic Approaches to Occupational Exposure-Associated Allergic and Non-Allergic Asthmatic Disease
Aaron Schwab, Jill A. Poole
Current Allergy and Asthma Reports (2023) Vol. 23, Iss. 6, pp. 313-324
Open Access | Times Cited: 6
Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences
Agnieszka Kaczmarska, Dominika Kwiatkowska, Katarzyna Konstancja Skrzypek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14734-14734
Open Access | Times Cited: 6
Nemolizumab: un innovador tratamiento biológico para el control de la interleuquina 31 (IL-31) clave en la dermatitis atópica y el prurigo nodular
E. Serra‐Baldrich, Luis F. Santamaria‐Babí, J.F. Silvestre
Actas Dermo-Sifiliográficas (2021) Vol. 113, Iss. 7, pp. 674-684
Open Access | Times Cited: 15
Soluble mediators in the function of the epidermal-immune-neuro unit in the skin
Ewa Oleszycka, Kamila Kwiecień, Patrycja Kwiecińska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Topical treatment with mastic (resin from Pistacia lentiscus) elicits anti-inflammatory and anti-pruritic responses by modulating keratinocyte activation in a mouse model of allergic dermatitis
Risako Kishimoto, Narumi Kato, Mayuka Koike, et al.
Phytomedicine (2021) Vol. 91, pp. 153679-153679
Closed Access | Times Cited: 14
A New Era with the Development of Cytokine-Based Therapy for Pruritus
Rintaro Shibuya, Riko Takimoto‐Ito, Naotomo Kambe, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 1, pp. 47-52
Open Access | Times Cited: 14
The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect?
Karolina Świerczyńska-Mróz, Piotr Krajewski, Danuta Nowicka‐Suszko, et al.
Toxins (2022) Vol. 14, Iss. 3, pp. 197-197
Open Access | Times Cited: 9
Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges
Hyung-Ook Kim
Archives of Pharmacal Research (2022) Vol. 45, Iss. 12, pp. 894-908
Closed Access | Times Cited: 9
Clinical trials of antibody drugs in the treatments of atopic dermatitis
Guihao Zhou, Yueyao Huang, Ming Chu
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Therapeutic potential of ozone water treatment in alleviating atopic dermatitis symptoms in mouse models: Exploring its bactericidal and direct anti-inflammatory properties
Mao Kaneki, Chiharu Ohira, Miyu Takahashi, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110920-110920
Closed Access | Times Cited: 5
Treatment Options for Troublesome Itch
Sumika Toyama, Mitsutoshi Tominaga, Kenji Takamori
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1022-1022
Open Access | Times Cited: 8
Serum Level of Interleukin-31 in Patients with Uremic Pruritus Undergoing Hemodialysis
Abd El Aziz El-Taweel, A.I. Mustafa, Mohamed Fouda, et al.
Benha Medical Journal (2024)
Open Access | Times Cited: 1
The role of mast cells and related molecules in itch of hidradenitis suppurativa
Mika Yamanaka‐Takaichi, Addison M. Demer, Christian L. Baum, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Closed Access | Times Cited: 1
Critical role of keratinocytes in cutaneous immune responses
Rakesh Kumar Gupta, Poonam Wasnik, Deepankar Mondal, et al.
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 502-522
Open Access | Times Cited: 1
Clinical effect of delgocitinib 0.5% ointment on atopic dermatitis eczema intensity and skin barrier function
Masatoshi Abe, Hajime Iizuka, Ikue Nemoto‐Hasebe, et al.
Journal of Cutaneous Immunology and Allergy (2021) Vol. 5, Iss. 2, pp. 38-46
Open Access | Times Cited: 9
Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options
Anne Sofie Frølunde, Malthe Alexander Knudsgaard Wiis, Hakim Ben Abdallah, et al.
Dermatology (2022) Vol. 238, Iss. 5, pp. 950-960
Open Access | Times Cited: 6
Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib
Dengmei Xia, Yue Xiao, Mengmeng Li, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 9
Open Access | Times Cited: 6
Autoimmune Connective Tissue Diseases-Related Pruritus: Proper Diagnosis and Possible Mechanisms
Lai‐San Wong, Yu-Ta Yen
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1772-1772
Open Access | Times Cited: 6
Therapeutics in chronic pruritus of unknown origin
Teresa Ju, Angelina Labib, Ashley Vander Does, et al.
Itch (2023) Vol. 8, Iss. 1, pp. e64-e64
Open Access | Times Cited: 3
Association of Periodontitis and Atopic Dermatitis with the Levels of IL-13, IL-31, and TSLP in the Gingival Crevicular Fluid
Constanza Jiménez, Javier Martín Fernández, Marcela Aroca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15592-15592
Open Access | Times Cited: 3
The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development
Kazufumi Kunimura, Yoshinori Fukui
International Immunology (2021) Vol. 33, Iss. 12, pp. 731-736
Open Access | Times Cited: 8

Scroll to top